High-Dose Statins Prior to Percutaneous Coronary Intervention: A Paradigm Shift to Influence Clinical Outcomes in the Cardiac Catheterization Laboratory⁎
Refers to article:
Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction
, 10 August 2009
Carlo Briguori, Gabriella Visconti, Amelia Focaccio, Bruno Golia, Alaide Chieffo, Alfredo Castelli, Marco Mussardo, Matteo Montorfano, Bruno Ricciardelli, Antonio Colombo
Journal of the American College of Cardiology
1 December 2009 (Vol. 54, Issue 23, Pages 2157-2163) Abstract |
Full Text |
Full-Text PDF (629 KB)
No abstract is available. To read the body of this article, please view the Full Text online.
Vascular Medicine Program, University of California San Diego, La Jolla, California
Reprint requests and correspondence: Dr. Sotirios Tsimikas, Vascular Medicine Program, University of California San Diego, La Jolla, California 92093-0682
Dr. Tsimikas is on the Speakers' Bureau of Merck, has received investigator-initiated grants from Pfizer, Novartis, and GlaxoSmithKline, and has patent and patent applications for antibodies to oxidized LDL.
⁎ Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
